Structural Basis for EPC1-Mediated Recruitment of MBTD1 into the NuA4/TIP60 Acetyltransferase Complex. Read more about Structural Basis for EPC1-Mediated Recruitment of MBTD1 into the NuA4/TIP60 Acetyltransferase Complex.
The RESOLUTE consortium: unlocking SLC transporters for drug discovery. Read more about The RESOLUTE consortium: unlocking SLC transporters for drug discovery.
New Insights into 4-Anilinoquinazolines as Inhibitors of Cardiac Troponin I-Interacting Kinase (TNNi3K). Read more about New Insights into 4-Anilinoquinazolines as Inhibitors of Cardiac Troponin I-Interacting Kinase (TNNi3K).
Importance of Quantifying Drug-Target Engagement in Cells. Read more about Importance of Quantifying Drug-Target Engagement in Cells.
Crystal structure of DRIK1, a stress-responsive receptor-like pseudokinase, reveals the molecular basis for the absence of ATP binding. Read more about Crystal structure of DRIK1, a stress-responsive receptor-like pseudokinase, reveals the molecular basis for the absence of ATP binding.
Telomere dysfunction cooperates with epigenetic alterations to impair murine embryonic stem cell fate commitment. Read more about Telomere dysfunction cooperates with epigenetic alterations to impair murine embryonic stem cell fate commitment.
CDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse model. Read more about CDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse model.
L-thyroxin and the non-classical thyroid hormone TETRAC are potent activators of PPARγ. Read more about L-thyroxin and the non-classical thyroid hormone TETRAC are potent activators of PPARγ.
Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma. Read more about Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma.
Discovery of a First-in-class Protein Arginine Methyltransferase 6 (PRMT6) Covalent Inhibitor. Read more about Discovery of a First-in-class Protein Arginine Methyltransferase 6 (PRMT6) Covalent Inhibitor.
